Primary Immunosuppression With Tacrolimus in Renal Transplantation: A Single Center Experience
- H.C. Kim; S.B. Park; S.Y. Han; E.A. Whang; D.S. Jeon; H.T. Kim; W.H. Cho; C.H. Park
- Publication Year
- Tacrolimus (FK-506) has shown potent immunosuppressive activity both in vitro and in vivo.¹,² Previous clinical trials in Japan, Europe, and the United States suggest that tacrolimus is an effective primary immunosuppressive agent in kidney transplantation3-5 The present retrospective, nonrandomized single-center study was performed to confirm the efficacy and safety of tacrolimus as a primary immunosuppressive agent in kidney transplantation.
- Authorize & License
- Files in This Item:
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.